Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril.
Open Access
- 1 April 1985
- Vol. 53 (4), 431-435
- https://doi.org/10.1136/hrt.53.4.431
Abstract
The contribution of the renin-angiotensin system to the cardiovascular response to exercise was studied in 12 patients with congestive heart failure. The haemodynamic effects of captopril were measured at rest and during supine bicycle exercise. After captopril administration, resting systemic vascular resistance fell by 26.6% and mean blood pressure by 16.7% and cardiac index increased by 19.7%. During exercise, captopril decreased systemic vascular resistance by 25.6% and mean blood pressure by 8.2% and increased cardiac index by 24.4%. Pulmonary wedge pressure fell by 25% at rest but was not altered by captopril during exercise. Pretreatment plasma renin activity increased from 13.4(16.0) ng/ml/hr (10.3(12.3) mmol/l/hr) at rest to 20.0(27.8) ng/ml/hr (15.4(21.4) mmol/l/hr) during exercise. Pretreatment plasma noradrenaline concentration increased from 659(433) pg/ml (39(25.6) nmol/l) at rest to 2622(1486) pg/ml during exercise (155(88) nmol/l). Captopril favourably alters systemic vascular resistance and cardiac index during exercise in patients with congestive heart failure. This may reflect inhibition of the increased activity of the renin-angiotensin system during exercise in these patients and a subsequent reduction in systemic vasoconstriction.This publication has 30 references indexed in Scilit:
- Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study.Circulation, 1983
- Regional and systemic metabolic effects of angiotensin-converting enzyme inhibition during exercise in patients with severe heart failure.Circulation, 1982
- Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure.Circulation, 1981
- Angiotensin inhibition in severe heart failure: Acute central and limb hemodynamic effects of captopril with observations on sustained oral therapyAmerican Heart Journal, 1981
- Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.Circulation, 1980
- Sustained Effectiveness of Converting-Enzyme Inhibition in Patients with Severe Congestive Heart FailureNew England Journal of Medicine, 1980
- Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.Circulation, 1980
- Central and peripheral hemodynamic effects of angiotensin inhibition in patients with refractory congestive heart failure.Circulation, 1980
- Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting EnzymeNew England Journal of Medicine, 1979
- Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure.Circulation, 1978